Lipoprotein (a)

IL-6 Linked to Coronary Artery Disease Risk Associated With Elevated Lipoprotein(a)

This entry was posted in Cardiovascular Diseases and tagged CAD IL-6 Lipoprotein (a) Risk on

Elevated lipoprotein(a) [Lp(a)] was associated with a substantially higher risk of developing coronary artery disease (CAD) when accompanied by higher levels of the inflammatory biomarker interleukin-6 (IL-6), highlighting the important role of inflammation in modifying cardiovascular risk. In this UK Biobank study of 43,512 adults without preexisting CAD or aortic […]

Geographical Variation in Lipoprotein (a) Levels Among CHD Patients

This entry was posted in Cardiovascular Diseases and tagged CHD Lipoprotein (a) Variation on

A global study suggested that most patients with coronary heart disease (CHD) have Lipoprotein (a) [Lp(a)] levels below risk-enhancing thresholds with wide geographical variations. The study assessed Lp(a) levels in 3,928 CHD patients across 13 countries in six World Health Organization regions. Median Lp(a) level was 32 nmol/L, with 17.6% […]